The needless loss of 22,000 lives in Florida and Texas
Effective vaccines against the coronavirus have been widely available and free across the country since May. Yet in that time, about 150,000 people have died of COVID-19. Low vaccine uptake is largely to blame — regions with high rates of vaccination have done comparatively well, while those with low rates have suffered shattering outbreaks that crushed hospital systems.
As detailed at The Lancet, Pratha Sah and other scientists conducted an experiment to estimate what this meant in Texas and Florida. Their method is simple: Take the best-performing states (Vermont, Connecticut, Massachusetts, Maine, and Rhode Island, which achieved an average of 74 percent of adults vaccinated by July 31) as a benchmark for what high vaccine use could achieve, then run a computer simulation to calculate how much transmission, hospitalization, and death from COVID-19 could have been avoided in less-vaccinated Texas and Florida if they'd met that benchmark.
The study found that if Texas and Florida had kept up with the leaders, they would have prevented approximately:
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
- 1,311,900 COVID-19 cases
- 95,000 hospital admissions
- 22,000 deaths
Similar calculations could be run elsewhere, with similarly miserable results. Today, big chunks of the Midwest, Mountain West, and Great Plains regions are still far, far below herd immunity levels of vaccination, and sure enough, they are seeing Delta variant waves as temperatures cool off and socializing moves indoors. The more vaccine uptake can be encouraged or mandated, the more lives will be saved.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Ryan Cooper is a national correspondent at TheWeek.com. His work has appeared in the Washington Monthly, The New Republic, and the Washington Post.
-
Today's political cartoons - November 19, 2024
Cartoons Tuesday's cartoons - junk food, health drinks, and more
By The Week US Published
-
Band Aid 40: time to change the tune?
In the Spotlight Band Aid's massively popular 1984 hit raised around £8m for famine relief in Ethiopia and the charity has generated over £140m in total
By Rebekah Evans, The Week UK Published
-
Starmer vs the farmers: who will win?
Today's Big Question As farmers and rural groups descend on Westminster to protest at tax changes, parallels have been drawn with the miners' strike 40 years ago
By The Week UK Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
The bird flu fight is faltering
Talking Points Are pandemic lessons going unheeded?
By Joel Mathis, The Week US Published
-
OTC birth control arrives amid the battle over reproductive rights
Talking Points Opill will cost $19.99 a month. Democrats are pushing to make it cheaper.
By Joel Mathis, The Week US Published
-
What Florida is — and isn't — doing to curb the biggest measles outbreak in the US
Talking Points DeSantis appointee defies expert consensus to stop the spread
By Joel Mathis, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
No, it's not over
Talking Point New Omicron subvariants are headed our way
By William Falk Published